Startseite>>Signaling Pathways>> GPCR/G protein>> Glucagon Receptor>>Glucagon receptor antagonists-4

Glucagon receptor antagonists-4 (Synonyms: GCGR Antagonist IV)

Katalog-Nr.GC19170

Glucagon-Rezeptor-Antagonisten-4 ist ein hochwirksamer, nicht-peptidischer und oral aktiver Glucagon-Rezeptor-Antagonist.

Products are for research use only. Not for human use. We do not sell to patients.

Glucagon receptor antagonists-4 Chemische Struktur

Cas No.: 1393124-08-7

Größe Preis Lagerbestand Menge
1mg
27,00 $
Auf Lager
5mg
63,00 $
Auf Lager
10mg
90,00 $
Auf Lager
50mg
351,00 $
Auf Lager
100mg
612,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Glucagon receptor antagonists-4 is a highly potent glucagon receptor antagonist. It displays low in vivo clearance and excellent oral bioavailability in both rats and dogs.

References:
[1]. Guzman-Perez A et al. The design and synthesis of a potent glucagon receptor antagonist with favorable physicochemical andpharmacokinetic properties as a candidate for the treatment of type 2 diabetes mellitus. Bioorg Med Chem Lett, 2013 May 15, 23(10):3051-8.
[2]. Esther C.Y. Lee et al. Identification of a novel conformationally constrained glucagon receptor antagonist. Bioorg Med Chem Lett, 2014 Feb 1, 24(3):839-44.

Bewertungen

Review for Glucagon receptor antagonists-4

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Glucagon receptor antagonists-4

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.